Nine major pharmaceutical companies agree to lower US drug prices under Trump plan
WASHINGTON — Nine of the largest US and European based pharmaceutical companies agreed Friday to voluntarily lower the cost of certain prescription medications in the United States, as the Trump administration seeks to tie domestic drug prices to lower prices abroad. The deal includes Merck, Bristol Myers Squibb, Amgen, Gilead, GSK, Sanofi, Roche’s Genentech, privately … Read more


